Wegovy is not recommended in patients with severe gastroparesis Hypersensitivity Reactions: Serious hypersensitivity reactions (e.g., anaphylaxis, angioedema) have been reported with Wegovy
We also evaluated circulating DPP4 levels and substrates in a patient population undergoing treatment for HCV
Translating those results to humans would require crossing several large gaps: different species, different molecule, different delivery route, and different endpoints
GLP-1 Meal Replacement Market Outlook 2036 with Key Contributions from Huel, Nestl Health Science, BOOST, ADM, Smoothie King, and Herbalife by FMI Research Report GLP-1 Meal Replacement Market Driven by Rising Demand for Smaller, Nutrient-Dense, and High-Protein Nutrition Formats to Register 16.3% CAGR Growth Through 2036 NEWARK, DE / ACCESS Newswire / May 7, 2026 / According to the latest market analysis by Future Market Insights (FMI), the global GLP-1 meal replacement market is entering a high-growth phase as reduced-appetite eating behavior linked to GLP-1 therapies reshapes consumer nutrition preferences